All
Late Effects Burden Lymphoma Survivors After Multimodality Treatment
February 28th 2018Many patients with lymphoma need treatment with both chemotherapy and radiation, but these treatments may be accompanied by significant late-term effects, according to a new study presented during the 2018 American Society of Clinical Oncology Cancer Survivorship Symposium.
FDA Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer
February 27th 2018The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.
Ultra-Processed Foods May Increase Cancer Risk
February 23rd 2018Ultra-processed foods include items such as packaged bread products, sweet and savory packaged snacks, industrialized desserts, highly processed and/or preserved meat products, instant noodles and soups and other shelf-stable items, which usually have a high sugar, oil and/or fat content.